Author: Staddon Douglas
Publisher: Maney Publishing
ISSN: 1757-093X
Source: Pharmaceutical Programming, Vol.4, Iss.1-2, 2011-12, pp. : 74-80
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
SAS/GRAPH ?/sup>: should we use classic procedures or ODS templates?
Pharmaceutical Programming, Vol. 3, Iss. 1, 2010-06 ,pp. :
Paracetamol restrictions may have reduced ODs in the UK
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
High resource use and costs in type 1 diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 324, 2001-01 ,pp. :
Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus
Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. :